Skip to main content
. 2021 Apr 29;26(7):560–e1103. doi: 10.1002/onco.13777
Title PFS
Number of Patients Screened 75
Number of Patients Enrolled 75
Number of Patients Evaluable for Toxicity 74
Number of Patients Evaluated for Efficacy 75
Evaluation Method RECIST 1.1
(Median) Duration Assessments PFS 11.4 Months, CI: 5.8–NE